However, these studies may seriously underestimate the true incidence of NOTCH1 deregulation in CLL, considering that ~ 20% of NOTCH1‐mutated tumors were also mutated in the 3′‐UTR region. This evidence concerns the gene NOTCH1 and B-cell chronic lymphocytic leukemia.